Unexplained week-to-week variation in BNP and NT-proBNP is low in chronic heart failure patients during steady state.
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
Unexplained week-to-week variation in BNP and NT-proBNP is low in chronic heart failure patients during steady state. / Schou, Morten; Gustafsson, Finn; Nielsen, Per H; Madsen, Lene H; Kjaer, Andreas; Hildebrandt, Per R.
In: European Journal of Heart Failure, Vol. 9, No. 1, 2006, p. 68-74.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Unexplained week-to-week variation in BNP and NT-proBNP is low in chronic heart failure patients during steady state.
AU - Schou, Morten
AU - Gustafsson, Finn
AU - Nielsen, Per H
AU - Madsen, Lene H
AU - Kjaer, Andreas
AU - Hildebrandt, Per R
N1 - Keywords: Aged; Aged, 80 and over; Algorithms; Biological Markers; Female; Heart Failure; Humans; Male; Middle Aged; Monitoring, Physiologic; Natriuretic Peptide, Brain; Patient Selection; Peptide Fragments; Reference Values; Reproducibility of Results; Ventricular Dysfunction, Left; Ventricular Function, Left
PY - 2006
Y1 - 2006
N2 - BACKGROUND: The usefulness of brain-natriuretic-peptide (BNP) and N-terminal-pro-brain-natriuretic-peptide (NT-proBNP) for monitoring of chronic heart failure (CHF) patients has been questioned because of high levels of unexplained variation. AIMS: Week-to-week total variance (CV(T)), unexplained variation (CV(I)), reference change values (RCV), index of individualities (IOI) and number of samples (N) with week-to-week intervals needed to estimate the underlying homeostatic set point (+/-15%) for BNP and NT-proBNP were calculated in pre-specified stable CHF patients. METHODS AND RESULTS: We measured plasma concentrations of BNP and NT-proBNP, clinical and laboratory variables in 20 CHF patients with a 7-days interval. Only patients considered to be in steady state were included. The CV(I) was 15% (BNP) and 8% (NT-proBNP). CV(T) was 16% (BNP) and 8% (NT-proBNP) and RCV was 43% (BNP) and 23% (NT-proBNP). IOI was 0.14 for BNP and 0.03 for NT-proBNP and N was 1 for BNP and 1 for NT-proBNP. CONCLUSIONS: Our data demonstrate that unexplained variation of BNP and NT-proBNP is low in CHF patients during steady state, which is a prerequisite for the use of these peptides for monitoring of the disease.
AB - BACKGROUND: The usefulness of brain-natriuretic-peptide (BNP) and N-terminal-pro-brain-natriuretic-peptide (NT-proBNP) for monitoring of chronic heart failure (CHF) patients has been questioned because of high levels of unexplained variation. AIMS: Week-to-week total variance (CV(T)), unexplained variation (CV(I)), reference change values (RCV), index of individualities (IOI) and number of samples (N) with week-to-week intervals needed to estimate the underlying homeostatic set point (+/-15%) for BNP and NT-proBNP were calculated in pre-specified stable CHF patients. METHODS AND RESULTS: We measured plasma concentrations of BNP and NT-proBNP, clinical and laboratory variables in 20 CHF patients with a 7-days interval. Only patients considered to be in steady state were included. The CV(I) was 15% (BNP) and 8% (NT-proBNP). CV(T) was 16% (BNP) and 8% (NT-proBNP) and RCV was 43% (BNP) and 23% (NT-proBNP). IOI was 0.14 for BNP and 0.03 for NT-proBNP and N was 1 for BNP and 1 for NT-proBNP. CONCLUSIONS: Our data demonstrate that unexplained variation of BNP and NT-proBNP is low in CHF patients during steady state, which is a prerequisite for the use of these peptides for monitoring of the disease.
U2 - 10.1016/j.ejheart.2006.05.001
DO - 10.1016/j.ejheart.2006.05.001
M3 - Journal article
C2 - 16829184
VL - 9
SP - 68
EP - 74
JO - European Journal of Heart Failure
JF - European Journal of Heart Failure
SN - 1567-4215
IS - 1
ER -
ID: 8465174